597 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. D'Angelica
    D'Angelica
  4. Jarnagin
    Jarnagin
  5. Kemeny
    Kemeny
  6. Lichtman
    Lichtman
  7. Fong
    Fong
  8. Gonen
    Gonen
  9. Ilson
    Ilson
  10. Kingham
    Kingham

Groups

  1. Department of Medicine (407)
  2. Solid Tumor Oncology Division (372)
  3. Gastrointestinal Oncology Service (293)
  4. Center for Pancreatic Cancer Research (179)
  5. Surgery (167)
  6. Epidemiology and Biostatistics (76)
  7. Survivorship Research (76)
  8. Biostatistics Service (68)
  9. Population Sciences Research Program (63)
  10. Colorectal Surgery (59)
  1. "oxaliplatin"
Formats
  1. Journal Article (538)
  2. Review (36)
  3. Editorial (11)
  4. Correspondence (3)
  5. Conference Paper (2)
  6. Meeting Abstract (2)
  7. Miscellaneous (2)
  8. Book Section (1)
  9. Guidelines (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (407)
  2. Solid Tumor Oncology Division (372)
  3. Gastrointestinal Oncology Service (293)
  4. Center for Pancreatic Cancer Research (179)
  5. Surgery (167)
  6. Epidemiology and Biostatistics (76)

More Groups

People
  1. Leonard Saltz (84)
  2. Nancy Kemeny (74)
  3. Eileen O'Reilly (64)
  4. Michael D'Angelica (51)
  5. William Jarnagin (49)
  6. Stuart Lichtman (45)

More People

Years
  1. 2025 (20)
  2. 2024 (55)
  3. 2023 (33)
  4. 2022 (27)
  5. 2021 (13)
  6. 2020 (17)

More Years

Publications
  1. Journal of Clinical Oncology (42)
  2. Annals of Surgical Oncology (38)
  3. Journal of the National Comprehensive Cancer Network (29)
  4. The Oncology Report (26)
  5. Annals of Oncology (16)
  6. Cancer (16)

More Publications

Publishers
  1. Elsevier Inc. (99)
  2. Springer (75)
  3. American Society of Clinical Oncology (46)
  4. Oxford University Press (40)
  5. Wiley Blackwell (33)
  6. Elsevier Science, Inc. (29)

More Publishers

Results (597)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: Analysis of number needed to treat and number needed to harm
    Journal Article

    Sugarman, R.; Betts, K. A.; Nie, X.; Hartman, J.; Nguyen, H.
    Clinical Therapeutics (2023)

    Fulltext@MSK | Save
  • Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis of seven trials
    Journal Article

    Taieb, J.; Sinicrope, F. A.; Pederson, L.; Lonardi, S.; Alberts, S. R.; George, T. J.; Yothers, G.; Van Cutsem, E.; Saltz, L.; Ogino, S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Phase Ib/II study of the efficacy and safety of binimetinib (MEK162) plus panitumumab for mutant or wild-type RAS metastatic colorectal cancer
    Journal Article

    Van Cutsem, E.; Yaeger, R.; Delord, J. P.; Tabernero, J.; Siu, L. L.; Ducreux, M.; Siena, S.; Elez, E.; Kasper, S.; Zander, T.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Timing of initiation of palliative chemotherapy in asymptomatic patients with metastatic pancreatic cancer: An international expert survey and case-vignette study
    Journal Article

    Augustinus, S.; van Laarhoven, H. W. M.; Cirkel, G. A.; de Groot, J. W. B.; Groot Koerkamp, B.; Macarulla, T.; Melisi, D.; O’Reilly, E. M.; van Santvoort, H. C.; Mackay, T. M.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • The effect of histopathological growth patterns of colorectal liver metastases on the survival benefit of adjuvant hepatic arterial infusion pump chemotherapy
    Journal Article

    Filipe, W. F.; Meyer, Y. M.; Buisman, F. E.; Coebergh van den Braak, R. R. J.; Galjart, B.; Höppener, D. J.; Jarnagin, W. R.; Kemeny, N. E.; Kingham, T. P.; Nierop, P. M. H.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Combined hepatic arterial infusion pump and systemic chemotherapy in the modern era for chemotherapy-naive patients with unresectable colorectal liver metastases
    Journal Article

    Verheij, F. S.; Kuhlmann, K. F. D.; Silliman, D. R.; Soares, K. C.; Kingham, T. P.; Balachandran, V. P.; Drebin, J. A.; Wei, A. C.; Jarnagin, W. R.; Cercek, A.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Combined hepatic artery infusion pump and systemic chemotherapy in the modern era for chemotherapy-naive patients with unresectable colorectal liver metastases
    Miscellaneous

    Verheij, F. S.; Kuhlmann, K. F. D.; Silliman, D. R.; Soares, K. C.; Kingham, T. P.; Balachandran, V. P.; Drebin, J. A.; Wei, A. C.; Jarnagin, W. R.; Cercek, A.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): A randomised, open-label, phase 3 trial
    Journal Article

    Wainberg, Z. A.; Melisi, D.; Macarulla, T.; Pazo Cid, R.; Chandana, S. R.; De La Fouchardière, C.; Dean, A.; Kiss, I.; Lee, W. J.; Goetze, T. O.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • ILUSTRO: Phase II multicohort trial of zolbetuximab in patients with advanced or metastatic claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma
    Journal Article

    Klempner, S. J.; Lee, K. W.; Shitara, K.; Metges, J. P.; Lonardi, S.; Ilson, D. H.; Fazio, N.; Kim, T. Y.; Bai, L. Y.; Moran, D.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save